Searched for
BIOCON PHARMA INC
ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
Biocon inaugurates first manufacturing facility in USBiocon Ltd has inaugurated its first US manufacturing facility in Cranbury, New Jersey, operated by its subsidiary, Biocon Generics Inc. Fo...
Biocon plans $150-million capex in two yearsBiocon plans a $150 million capital expenditure, allocating $100 million to biologics, primarily enhancing Malaysian capacities, and $50 mi...
Glenmark, Biocon units recall products in US: USFDAGlenmark and Biocon are recalling products in the U.S. due to manufacturing issues. Glenmark is recalling 8,160 bottles of chlorpromazine h...
Q2 results this week: Airtel, Maruti Suzuki, L&T among 392 companies to announce earningsThe second quarter earnings season for India Inc. is expected to be muted, with possibly the slowest growth in over four years. Major compa...
Stocks in news: IDFC First Bank, Kotak Mahindra Bank, IDBI Bank, Shaily Engineering, RVNLGMR Smart Electricity Distribution, a step down subsidiary of GMR Power and Urban Infra, has received a letter of award (LOA) from Purvanch...
Biocon acquires Eywa Pharma's US-based plant for $7.7 millionBiocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.’s oral solid dosage manufact...
Q1 results this week: LIC, Adani Ports, IRCTC, Hero MotoCorp, Nykaa and othersAdani Ports, Coal India, Siemens, Hindalco, Linde India, Lloyds Metals, Phoenix Mills, Oil India, Prestige Estates, Aarti Industries, Happi...
Viatris buys Taparias' eyecare business for Rs 2,460 croreThe ophthalmology portfolio consists of six new chemical entities (NCEs or molecules) that are under phase 3 trials and will be developed f...
Stocks in the news: Wipro, RIL, Hindalco, HDFC, Tata Steel, Welspun Corp and BioconIT major Wipro will announce its fourth-quarter and FY20 results today.
USFDA in active mode, issues obersvations to 4 drug makers in 3 days!SMS Pharma today informed exchanges that the United States Food and Drug Administration (USFDA) conducted a cGMP inspection at Kandivalasa,...
Share market update: Nifty Pharma lone sectoral gainer; Aurobindo Pharma jumps 5%The Nifty Pharma index was trading 1.35 per cent up at 10,442.2 around 12:50 pm.
Stock market update: Pharma stocks in good health; Divi's Labs, Lupin jump up to 3%The Nifty Pharma index was trading 0.97 per cent up at 10,047 around 10:30 am.
Roche sues Biocon, Mylan, DCGI over breast cancer drugRoche has sued Mylan, Biocon for launching biosimilar version of the original breast cancer drug, Herceptin, and DCGI for allowing the laun...
Biocon inks licensing pact with US-based Quark PharmaBiocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel thera...
- Biocon-Mylan partnership has a potential of $33 billion from biosimilar drugs
Two years after announcing a JV with Mylan, Biocon has revealed the potential of its drugs under the biologics deal with Mylan.
- Pfizer scraps Insulin pact with Biocon
Pfizer Inc has terminated a deal to sell Biocon's insulin products globally, dealing the Indian company a blow and calling into question si...
- Obama's tax worries pharma too
Apart from IT, the domestic pharma industry is also worried over President Obama's proposal to end tax breaks for US companies, which are e...
- Biocon picks up 70% in German pharma co AxiCorp for e30 mn
The deal will enable the Bangalore-based player to market its injectible insulin, generics, biosimilars and biologics in Europe.
- India falls behind in patents race
India is fourth among developing countries in filing for international patents. South Korea occupies the top slot followed by China and Sou...